S1P1 antagonists (Kissei Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameS1P1 antagonists (Kissei Pharmaceutical)
Drug Alias Namesphingosine-1-phosphate-1 receptor antagonists (Kissei Pharmaceutical)KSI-6666
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 antagonists
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKissei Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A